Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-08-05

Clinical Trial Update: Proton Pump Inhibitors Use in Patients With Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 Clinical Trial investigating proton pump inhibitors in patients with psoriasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: EMS | Conditions: Psoriasis | Phase 4 | Status: WITHDRAWN